Protein cross-match test for the diagnosis and prevention of reactions after the transfusion of blood and cryoprecipitate.
The examination by means of counterimmunoelectrophoresis for protein incompatibility of the serum of 62 patients who developed an allergic or pyretic post-transfusion reaction revealed incompatibility in 23 cases (37.2%). It was due to the presence of antibodies in 8 recipients (34.8%) and in 15 blood donors (65.2%). The incidence was significantly higher than in a control group of transfused patients who did not develop a reaction. In this group protein incompatibility was found in only 14.7%, 80% of which was due to antibodies in the recipient. In 13 (56.5%) of the patients with reactions agglutinating, cytotoxic or complement fixing antibodies against cellular antigens or IgG were found in addition to protein incompatibility. In 10 cases (43.5%) protein incompatibility was the only explanation for the clinical symptoms. When, in the treatment of multiply transfused haemophiliacs who regularly developed adverse reactions, donors for the preparation of cryoprecipitate were selected by means of the described technique, the almost obligatory reactions were prevented.
D000906:Antibodies; D001787:Blood Group Incompatibility / Q000175:diagnosis / Q000517:prevention & control*; D001798:Blood Proteins; D002648:Child; D003378:Counterimmunoelectrophoresis; D003429:Cross Reactions; D006801:Humans; D008297:Male; D065227:Transfusion Reaction
D000906:Antibodies; D001798:Blood Proteins